Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor

This publication has 10 references indexed in Scilit:

• Teaching old dogmas new tricks
  Nature, 1987
• Lovastatin (Mevinolin) in the Treatment of Heterozygous Familial Hypercholesterolemia
  Annals of Internal Medicine, 1987
• cDNA sequence of human apolipoprotein(a) is homologous to plasminogen
  Nature, 1987
• Structural Relationship of an Apolipoprotein (a) Phenotype (570 kDa) to Plasminogen: Homologous Kringle Domains are Linked by Carbohydrate-Rich Regions
  Biological Chemistry Hoppe-Seyler, 1987
• The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosisDependence on serum LDL levels
  Atherosclerosis, 1986
• Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits.
  Proceedings of the National Academy of Sciences, 1986
• Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.
  Circulation, 1986
• EFFECTS OF SYNVINOLIN (MK-733) ON PLASMA LIPIDS IN FAMILIAL HYPERCHOLESTEROLAEMIA
  The Lancet, 1986
• Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment
  Atherosclerosis, 1985
• Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a)
  Atherosclerosis, 1982